Inhibikase Therapeutics, Inc. · NASDAQ:IKT
Point72 Asset Management, L.P.'s stake in Inhibikase Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Point72 Asset Management, L.P.'s stake in Inhibikase Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 0% | 0 |
| Point72 Capital Advisors, Inc. | 0% | 0 |
| Steven A. Cohen | 0% | 0 |
Source
Related
- Inhibikase Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Inhibikase Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Aug 13, 2026
- Form 4 · Berman Dennis N · Jul 31, 2026
- Form 4 · RA Capital Healthcare Fund LP · Jul 31, 2026